| RS2150664716 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2150668444 |
FBXO31
|
Health Risk |
Pathogenic/Likely pathogenic |
Ectopic thyroid, Spastic cerebral palsy |
| RS2150669316 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150669574 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150669764 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150669783 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150669843 |
CHD7
|
Health Risk |
Pathogenic/Likely pathogenic |
CHARGE syndrome, CHD7-related disorder |
| RS2150669923 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150669944 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150669971 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150670337 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150674258 |
AIPL1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS2150674982 |
AIPL1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS2150675032 |
AIPL1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS2150675170 |
AIPL1
|
Health Risk |
Likely pathogenic |
Abnormality of the eye, Abnormality of the eye |
| RS2150676904 |
PMP22
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS2150677132 |
AIPL1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS2150678060 |
AIPL1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS2150680046 |
FGFR1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2150680264 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2150683817 |
GAN
|
Health Risk |
Likely pathogenic |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS2150685528 |
GAN
|
Health Risk |
Pathogenic |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS2150687333 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome, Treacher Collins syndrome |
| RS2150687380 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2150687507 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Hematuria |
| RS2150687608 |
GAN
|
Health Risk |
Pathogenic |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS2150687684 |
COL4A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2150688207 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2150690183 |
GAN
|
Health Risk |
Likely pathogenic |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS2150690197 |
GAN
|
Health Risk |
Pathogenic |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS2150691608 |
GAN
|
Health Risk |
Likely pathogenic |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS2150691981 |
GAN
|
Health Risk |
Pathogenic |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS2150695587 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS2150697457 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150697552 |
TPK1
|
Health Risk |
Pathogenic |
Childhood encephalopathy due to thiamine pyrophosphokinase deficiency, Childhood encephalopathy due to thiamine pyrophosphokinase deficiency |
| RS2150697555 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150697787 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150697832 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150702964 |
NHLRC1
|
Health Risk |
Pathogenic |
Lafora disease, Lafora disease |
| RS2150703022 |
NHLRC1
|
Health Risk |
Pathogenic |
Lafora disease, Lafora disease |
| RS2150703425 |
NHLRC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Lafora disease, Inborn genetic diseases |
| RS2150704850 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS2150705198 |
FGFR1
|
Health Risk |
Pathogenic |
Pfeiffer syndrome, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2150706662 |
TCOF1
|
Health Risk |
Likely pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS2150707502 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS2150708627 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150708828 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150708918 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150710134 |
PMP22
|
Health Risk |
Likely pathogenic |
Peripheral neuropathy, Peripheral neuropathy |
| RS2150710219 |
PMP22
|
Health Risk |
Likely pathogenic |
Dejerine-Sottas disease, Dejerine-Sottas disease |
| RS2150711063 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150711288 |
MYOCD
|
Health Risk |
Likely pathogenic |
Megabladder, congenital |
| RS2150713720 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS2150714943 |
TCOF1
|
Health Risk |
Pathogenic |
— |
| RS2150715791 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS2150716827 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS2150723965 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150723994 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS2150726644 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS2150728161 |
DNAH9
|
Health Risk |
Pathogenic |
— |
| RS2150729369 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2150732608 |
TCOF1
|
Health Risk |
Likely pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS2150732849 |
NEB
|
Health Risk |
Likely pathogenic |
— |
| RS2150734056 |
SUGCT
|
Health Risk |
Likely pathogenic |
Glutaryl-CoA oxidase deficiency, Glutaryl-CoA oxidase deficiency |
| RS2150734334 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS2150735761 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2150735809 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2150735961 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 12 |
| RS2150736114 |
BBS12
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 12 |
| RS2150736228 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2150736424 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 12, Bardet-Biedl syndrome 12 |
| RS2150736431 |
BBS12
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 12 |
| RS2150736605 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2150736616 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2150736647 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS2150736648 |
BBS12
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 12 |
| RS2150736842 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2150736854 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2150736865 |
BBS12
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 12, Bardet-Biedl syndrome 12 |
| RS2150736986 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2150737232 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 1 |
| RS2150737331 |
BBS12
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 12 |
| RS2150737344 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2150737598 |
BBS12
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 12 |
| RS2150737655 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2150737680 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2150737953 |
BBS12
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 12, Bardet-Biedl syndrome 12 |
| RS2150738027 |
BBS12
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 12, Bardet-Biedl syndrome 12 |
| RS2150739058 |
CHD7
|
Health Risk |
Pathogenic/Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150739129 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2150739132 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2150739928 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Hematuria |
| RS2150739953 |
COL4A4
|
Health Risk |
Pathogenic |
COL4A4-related disorder, Autosomal recessive Alport syndrome |
| RS2150741648 |
ASPA
|
Health Risk |
Pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS2150741666 |
ASPA
|
Health Risk |
Pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS2150741763 |
ASPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS2150741788 |
ASPA
|
Health Risk |
Pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS2150741844 |
ASPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS2150741916 |
ASPA
|
Health Risk |
Pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS2150746796 |
ASPA
|
Health Risk |
Pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |